info:eu-repo/semantics/article
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial
Registro en:
1932-6203 (Electrónico)
Autor
Cooper, David A.
Cordery, Damien V.
Zajdenverg, Roberto
Ruxrungtham, Kiat
Arastéh, Keikawus
Bergmann, Frank
Andrade Neto, José L. de
Scherer, Joseph
Chaves, Ricardo L.
Robinson, Patrick